These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17154040)

  • 1. [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine].
    Hamada Y; Miyamoto K; Inatsugi Y; Suzuki H; Kusunoki S
    Rinsho Shinkeigaku; 2006 Aug; 46(8):575-8. PubMed ID: 17154040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine.
    Gambassi G; Capurso S; Tarsitani P; Liperoti R; Bernabei R
    Aging Clin Exp Res; 2006 Jun; 18(3):266-70. PubMed ID: 16804375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
    Uguz F; Sonmez EÖ
    Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Pappa DA; Katritsis DE; Christodoulou GN
    J Clin Psychopharmacol; 2003 Dec; 23(6):671-2. PubMed ID: 14624202
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: a diagnosis easily missed.
    McDonough CM; Swift G; Managan B; Sheehan JD
    Ir Med J; 2000; 93(5):152-4. PubMed ID: 11072926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of paroxetine in Parkinson's disease: a prospective study.
    Tesei S; Antonini A; Canesi M; Zecchinelli A; Mariani CB; Pezzoli G
    Mov Disord; 2000 Sep; 15(5):986-9. PubMed ID: 11009210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
    Freijzer PL; Brenninkmeijer JH
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):574-5. PubMed ID: 11938583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y; Ogawa N
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment: delayed risperidone-induced neuroleptic malignant syndrome.
    Sitarz WE
    Ann Pharmacother; 1996 Nov; 30(11):1342-3. PubMed ID: 8913427
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].
    Saeki H; Muneta S; Kobayashi T
    Nihon Ronen Igakkai Zasshi; 1998 Feb; 35(2):139-44. PubMed ID: 9584493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?
    Stanford BJ; Stanford SC
    J Psychopharmacol; 1999; 13(3):313-7. PubMed ID: 10512094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report.
    Ohta R; Sano C
    Cureus; 2022 Feb; 14(2):e22468. PubMed ID: 35345760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome complicating levodopa withdrawal.
    Reutens DC; Harrison WB; Goldswain PR
    Med J Aust; 1991 Jul; 155(1):53-4. PubMed ID: 2067442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
    Yamawaki Y; Ogawa N
    Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Mizuno Y; Takubo H; Mizuta E; Kuno S
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.